Drugs / GEH200521
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06398730 | Jul 2024 → Feb 2026 | — | GE Healthcare | Completed | No outcome recorded |
| Phase 1 | NCT05629689 | Jan 2023 → Mar 2029 expected | cancer | GE Healthcare | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GEH200521 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06398730 ↗ |